Pell Bio-Med Technology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	37,065	20,062	4,722	-	-	-
Market Cap Growth	393.26%	324.81%	-	-	-	-
Enterprise Value	36,264	19,862	3,796	-	-	-
Last Close Price	574.00	342.50	81.01	-	-	-
PS Ratio	1179.53	638.42	240.56	-	-	-
PB Ratio	21.88	11.84	3.67	-	-	-
P/TBV Ratio	26.12	14.14	4.01	-	-	-
EV/Sales Ratio	-	632.08	193.39	-	-	-
Debt / Equity Ratio	0.14	0.14	0.28	0.15	0.25	0.60
Net Debt / Equity Ratio	-0.63	-0.63	-0.60	-0.79	-0.62	0.09
Net Debt / EBITDA Ratio	2.56	2.56	1.96	2.38	2.33	-0.11
Net Debt / FCF Ratio	2.12	2.12	1.47	4.75	3.02	-0.16
Asset Turnover	0.02	0.02	0.01	0.02	0.02	-
Inventory Turnover	5.60	5.60	6.43	10.59	6.45	-
Quick Ratio	4.27	4.27	3.55	12.47	12.49	2.86
Current Ratio	4.31	4.31	3.60	12.62	12.67	2.98
Return on Equity (ROE)	-30.38%	-30.38%	-32.02%	-40.20%	-44.50%	-
Return on Assets (ROA)	-15.15%	-15.15%	-16.34%	-20.88%	-20.52%	-
Return on Capital Employed (ROCE)	-25.90%	-25.90%	-29.00%	-30.90%	-23.90%	-56.00%
Earnings Yield	-1.14%	-2.11%	-8.25%	-	-	-
FCF Yield	-1.37%	-2.53%	-11.09%	-	-	-
Buyback Yield / Dilution	-2.77%	-2.77%	-23.33%	-17.94%	-17.87%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.